NCT04085133

Brief Summary

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 11, 2019

Completed
15 days until next milestone

Study Start

First participant enrolled

September 26, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

February 17, 2023

Status Verified

September 1, 2019

Enrollment Period

3 months

First QC Date

May 28, 2019

Last Update Submit

February 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • To study prevalence of bronchiectasis in TB patients by case per year.

    How many patients of TB will be diagnosed as abronchiectasis

    One year

Secondary Outcomes (1)

  • To evaluate the burden of bronchiectasis in TB patients

    one year

Interventions

Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Any tuberculosis patients admited to assuit university hospital and assuit chest hospital

You may qualify if:

  • patients were diagnosed to have tuberculosis by sputum culture and gene x pert.
  • patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score.
  • patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.

You may not qualify if:

  • patients presented with other Pulmonary diseases. 2-Chronic liver and renal disease . 3- Lung cancer and tumors. 4- patients were previously diagnosed as bronchiectasis .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut unviresty

Asyut, 71511, Egypt

Location

Biospecimen

Retention: SAMPLES WITH DNA

Sputum by gene xpert

MeSH Terms

Conditions

Tuberculosis, Pulmonary

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
2 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DR.Ahmad Shaddad

Study Record Dates

First Submitted

May 28, 2019

First Posted

September 11, 2019

Study Start

September 26, 2019

Primary Completion

January 1, 2020

Study Completion

April 1, 2020

Last Updated

February 17, 2023

Record last verified: 2019-09

Locations